Skip to content

Biocubik: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Biocubik

BE 0782.955.294
NACE 72.101, Research and development on biotechnology
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€48,134
2024 · -€152,576+€104,442
Equity
€500,040
2024 · €19,248+€480,792
Cash
€182,578
2024 · €111,002+€71,576
Balance sheet total
€592,794
2024 · €125,570+€467,225

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€209,143

    up €209,143 (+2,439%), from €8,574 to €217,717

    of which Other amounts receivable: +€205,874

  • Stocks and contracts +€105,000

    new in 2025: €105,000

  • Intangible fixed assets +€82,990

    new in 2025: €82,990

  • Cash +€71,576

    up €71,576 (+64.5%), from €111,002 to €182,578

    mainly Contributions, distributions and other (+€528,926) and Other debts (+€30,000)

Equity and liabilities
  • Investment grants +€278,926

    new in 2025: €278,926

  • Contributions +€250,000

    up €250,000 (+83.3%), from €300,000 to €550,000

  • Debts after one year -€60,000

    down €60,000 (-82.8%), from €72,500 to €12,500

  • Profit (loss) carried forward -€48,134

    down €48,134 (-17.1%), from -€280,752 to -€328,886

  • Other debts +€30,000

    up €30,000 (+11,422%), from €263 to €30,263

Income statement
  • Gross operating margin +€144,181

    up €144,181, from -€76,117 to €68,064

  • Staff costs +€30,993

    up €30,993 (+40.1%), from €77,204 to €108,197

  • Financial charges +€5,163

    up €5,163, from -€2,709 to €2,454

  • Depreciation +€5,103

    up €5,103 (+385%), from €1,326 to €6,429

  • Financial income +€2,050

    new in 2025: €2,050

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€152,576
Gross operating margin +€144,181
Staff costs -€30,993
Depreciation -€5,103
Other operating charges -€501
Financial income +€2,050
Financial charges -€5,163
Taxes -€29
Result 2025 -€48,134
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€310,125
Investment -€87,224
Financing +€468,926
Cash 2024 €111,002
Net result for the year -€48,134
Depreciation +€6,429
Stocks and contracts -€105,000
Receivables within one year -€209,143
Deferred charges and accrued income -€710
Trade debts +€23,949
Tax, wage and social debts -€7,516
Other debts +€30,000
Investment in fixed assets (net) -€87,224
Debts after one year -€60,000
Contributions, distributions and other +€528,926
Cash 2025 €182,578
brings cash intakes cash out
Every line side by side 42 lines
Line Code 2024 2025 Change %
Total assets 20/58 €125,570 €592,794 +€467,225 +372%
Fixed assets 21/28 €4,591 €85,386 +€80,795 +1,760%
Intangible fixed assets 21 - €82,990 +€82,990
Tangible fixed assets 22/27 €4,591 €2,396 -€2,195 -47.8%
Plant, machinery and equipment 23 €519 €57 -€462 -89.0%
Furniture and vehicles 24 €4,072 €2,339 -€1,733 -42.6%
Current assets 29/58 €120,978 €507,408 +€386,430 +319%
Stocks and contracts in progress 3 - €105,000 +€105,000
Contracts in progress 37 - €105,000 +€105,000
Amounts receivable within one year 40/41 €8,574 €217,717 +€209,143 +2,439%
Trade receivables 40 - €3,270 +€3,270
Other amounts receivable 41 €8,574 €214,448 +€205,874 +2,401%
Cash at bank and in hand 54/58 €111,002 €182,578 +€71,576 +64.5%
Deferred charges and accrued income 490/1 €1,403 €2,113 +€710 +50.6%
Total equity and liabilities 10/49 €125,570 €592,794 +€467,225 +372%
Equity 10/15 €19,248 €500,040 +€480,792 +2,498%
Contributions 10/11 €300,000 €550,000 +€250,000 +83.3%
Profit (loss) carried forward 14 -€280,752 -€328,886 -€48,134 -17.1%
Investment grants 15 - €278,926 +€278,926
Amounts payable 17/49 €106,322 €92,755 -€13,567 -12.8%
Amounts payable after more than one year 17 €72,500 €12,500 -€60,000 -82.8%
Other amounts payable 178/9 €72,500 €12,500 -€60,000 -82.8%
Amounts payable within one year 42/48 €33,822 €80,255 +€46,433 +137%
Trade debts 44 €13,823 €37,772 +€23,949 +173%
Suppliers 440/4 €13,823 €37,772 +€23,949 +173%
Taxes, remuneration and social security 45 €19,737 €12,220 -€7,516 -38.1%
Taxes 450/3 €2,194 €1,741 -€453 -20.6%
Remuneration and social security 454/9 €17,543 €10,479 -€7,063 -40.3%
Other amounts payable 47/48 €263 €30,263 +€30,000 +11,422%
Remuneration, social security and pensions 62 €77,204 €108,197 +€30,993 +40.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,326 €6,429 +€5,103 +385%
Other operating charges 640/8 €390 €892 +€501 +128%
Gross operating margin 9900 -€76,117 €68,064 +€144,181
Operating profit (loss) 9901 -€155,037 -€47,453 +€107,583 +69.4%
Financial income 75/76B - €2,050 +€2,050
Recurring financial income 75 - €2,050 +€2,050
Financial charges 65/66B -€2,709 €2,454 +€5,163
Recurring financial charges 65 -€2,709 €2,454 +€5,163
Profit (loss) for the period before taxes 9903 -€152,328 -€47,857 +€104,471 +68.6%
Income taxes 67/77 €248 €277 +€29 +11.6%
Profit (loss) for the period 9904 -€152,576 -€48,134 +€104,442 +68.5%
Profit (loss) for the period to be appropriated 9905 -€152,576 -€48,134 +€104,442 +68.5%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.